Cargando…
DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients
BACKGROUND: As biomarkers, DNA methylation is used to detect colorectal cancer (CRC) and make assessment of CRC prognosis. The published findings showed the association between the methylation of SFRP1, SFRP2, and WIF1, located in the Wnt signaling pathway, and the prognosis of CRC were not consiste...
Autores principales: | Liu, Xinyan, Fu, Jinming, Bi, Haoran, Ge, Anqi, Xia, Tingting, Liu, Yupeng, Sun, Hongru, Li, Dapeng, Zhao, Yashuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909551/ https://www.ncbi.nlm.nih.gov/pubmed/31830937 http://dx.doi.org/10.1186/s12885-019-6436-0 |
Ejemplares similares
-
DNA hypermethylation of MAL gene may act as an independent predictor of favorable prognosis in patients with colorectal cancer
por: Liu, Xinyan, et al.
Publicado: (2019) -
Coexpression of SFRP1 and WIF1 as a Prognostic Predictor of Favorable Outcomes in Patients with Colorectal Carcinoma
por: Huang, Shiyong, et al.
Publicado: (2014) -
Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2015) -
Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
por: Ghasemi, Ali, et al.
Publicado: (2015) -
Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma
por: Kumar, Alok, et al.
Publicado: (2019)